Search all trials

Find therapies in clinical trials near you – page 6

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Phase 1 Study of ADCT-901 in Patients with Advanced Solid Tumors to Evaluate Safety, Tolerability, Pharmacokinetics and Antitumor Activity

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Effect of Food on Absorption of 2-(3-(3,5-dimethyltriazol-4-yl)-5-((s)-oxan-4-yl(phenyl)methyl)pyrido(3,2-b)indol-7-yl)propan-2-ol in Advanced Solid Tumors Participants

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:2-(3-(3,5-Dimethyltriazol-4-Yl)-5-((S)-Oxan-4-Yl(Phenyl)Methyl)Pyrido(3,2-B)Indol-7-Yl)Propan-2-Ol

Contact Research Centre

Neoplasm malignant+6

Not recruiting

InvestigationalNo placebo

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cldn6 Car-T

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:S095035

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of GEN1078 for Patients with Malignant Solid Tumors

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:GEN1078

Contact Research Centre

Neoplasm malignant+2

Not recruiting

Registered drugNo placebo

Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Study on JAB-21822 for Adults with Advanced Solid Tumors with KRAS G12C Mutation

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Jab-21822

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Neoplasm malignant+13

Not recruiting

InvestigationalNo placebo

Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Fadraciclib

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Avelumab

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Tecaginlimab and Pembrolizumab with Radiotherapy for Patients with Metastatic Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 6

129 trials match your criteria

Neoplasm malignant

Phase 1 Study of ADCT-901 in Patients with Advanced Solid Tumors to Evaluate Safety, Tolerability, Pharmacokinetics and Antitumor Activity

Neoplasm malignant

Effect of Food on Absorption of 2-(3-(3,5-dimethyltriazol-4-yl)-5-((s)-oxan-4-yl(phenyl)methyl)pyrido(3,2-b)indol-7-yl)propan-2-ol in Advanced Solid Tumors Participants

Neoplasm malignant+6

A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

Neoplasm malignant

Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

Neoplasm malignant

Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

Neoplasm malignant

Study on the Safety and Effectiveness of GEN1078 for Patients with Malignant Solid Tumors

Neoplasm malignant+2

Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

Neoplasm malignant

Study on JAB-21822 for Adults with Advanced Solid Tumors with KRAS G12C Mutation

Neoplasm malignant

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

Neoplasm malignant+13

Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

Neoplasm malignant

Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

Neoplasm malignant

Study on the Safety and Effectiveness of Tecaginlimab and Pembrolizumab with Radiotherapy for Patients with Metastatic Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.